Each vial contains 6 ml of calfactant
Infasurf is used to prevent and treat respiratory distress syndrome in premature infants. Infrastructure reduces the incidence of neonatal respiratory distress syndrome and the resulting mortality rate.
Kimiara Pharmaceutical Company was established in 2005 as one of the subsidiaries of Ahran Tejarat Group.
All rights of this website belong to Kimiara Company. © 2023